Comparison of New Pharmacologic Agents With Triptans for Treatment of Migraine: A Systematic Review and Meta-analysis

IMPORTANCE: New therapeutic classes of migraine-specific treatment have been developed, including 5-hydroxytryptamine(1F) receptor agonists (lasmiditan) and calcitonin gene-related peptide antagonists (rimegepant and ubrogepant). OBJECTIVE: To compare outcomes associated with the use of lasmiditan,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chun-Pai, Liang, Chih-Sung, Chang, Ching-Mao, Yang, Cheng-Chia, Shih, Po-Hsuan, Yau, Yun-Chain, Tang, Kuo-Tung, Wang, Shuu-Jiun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506232/
https://www.ncbi.nlm.nih.gov/pubmed/34633423
http://dx.doi.org/10.1001/jamanetworkopen.2021.28544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506232/
https://www.ncbi.nlm.nih.gov/pubmed/34633423
http://dx.doi.org/10.1001/jamanetworkopen.2021.28544

Ejemplares similares